Skip to main content

Table 5 Diagnostic criteria of caAMRa

From: Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study)

  1. AMR Antibody-mediated rejection, DSA Donor-specific antibodies, caAMR chronic active antibody-mediated rejection
  2. aAt least one feature from each of the three criteria must be present for the diagnosis of caAMR
Back to article page

Trials

ISSN: 1745-6215